Research & Development

Are Metastatic Breast Cancer Rates Increasing Among U.S. Women?
Research & Development Are Metastatic Breast Cancer Rates Increasing Among U.S. Women?

Breast cancer remains a leading cause of cancer-related deaths among women in the United States. The prognosis of breast cancer is heavily dependent on the stage at which it is diagnosed, with early detection playing a crucial role in improving survival rates. However, recent research indicates a

Impact of Social Risks on Cancer Screening Among Underserved Communities
Research & Development Impact of Social Risks on Cancer Screening Among Underserved Communities

The relationship between social risks and routine cancer screenings signifies a complex and pressing public health issue, particularly regarding how housing instability or food insecurity among patients significantly hinders essential cancer preventive care. A new study conducted by researchers at

Can Nanofiber Vaccines Revolutionize Alzheimer's and Dementia Treatment?
Research & Development Can Nanofiber Vaccines Revolutionize Alzheimer's and Dementia Treatment?

Imagine a world where Alzheimer's disease and frontotemporal dementia could be combated not with costly and sometimes harmful treatments, but with vaccines specially designed to target specific proteins without causing inflammation. This innovative approach is currently being explored by

Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes
Research & Development Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes

In a groundbreaking study from Karolinska Institutet in Sweden, researchers have introduced an innovative method aimed at concurrently screening for liver fibrosis and eye disease in people living with type 2 diabetes. By combining liver damage screening with the already established retina scanning

Can mTOR Inhibitors Treat Rare Genetic Immunodeficiency Disorders?
Research & Development Can mTOR Inhibitors Treat Rare Genetic Immunodeficiency Disorders?

Genetic mutations causing rare immunodeficiency disorders present significant challenges to medical science, but recent advancements offer hope to affected individuals. University of Surrey researchers have made promising strides in understanding and potentially treating these conditions,

Can Cell-Penetrating Antibodies Revolutionize Cancer Treatment?
Research & Development Can Cell-Penetrating Antibodies Revolutionize Cancer Treatment?

Recent advancements in the field of monoclonal antibody (mAb) treatments have shown a promising shift towards more effective cancer therapies. The 3E10 antibody, initially identified in autoimmune mouse studies focused on systemic lupus erythematosus, has emerged as a game-changer. Unlike

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later